Insider · CIK 0001244106
Steven W King
Files at OTLC (Oncotelic Therapeutics, Inc.). First filing -, latest -.
In brief
Steven W King files SEC Form 4 as director at OTLC (Oncotelic Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Steven W King has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | OTLC Oncotelic Therapeutics, Inc. | AGrant or award Restricted stock Unitsderivative | +250 | $0.00 | $0 | 250 | Jul 21, 2026 |
Questions about Steven W King
Answered from the filings on this page, as of the latest one.
Is Steven W King buying or selling?
Steven W King has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Steven W King's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Steven W King has 0.
Where does Steven W King file Form 4?
Steven W King has filed Form 4 at OTLC (Oncotelic Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.